Structures of phi29 DNA polymerase complexed with substrate: the mechanism of translocation in B-family polymerases

Replicative DNA polymerases (DNAPs) move along template DNA in a processive manner. The structural basis of the mechanism of translocation has been better studied in the A‐family of polymerases than in the B‐family of replicative polymerases. To address this issue, we have determined the X‐ray cryst...

Full description

Saved in:
Bibliographic Details
Published inThe EMBO journal Vol. 26; no. 14; pp. 3494 - 3505
Main Authors Berman, Andrea J, Kamtekar, Satwik, Goodman, Jessica L, Lázaro, José M, de Vega, Miguel, Blanco, Luis, Salas, Margarita, Steitz, Thomas A
Format Journal Article
LanguageEnglish
Published Chichester, UK John Wiley & Sons, Ltd 25.07.2007
Blackwell Publishing Ltd
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Replicative DNA polymerases (DNAPs) move along template DNA in a processive manner. The structural basis of the mechanism of translocation has been better studied in the A‐family of polymerases than in the B‐family of replicative polymerases. To address this issue, we have determined the X‐ray crystal structures of phi29 DNAP, a member of the protein‐primed subgroup of the B‐family of polymerases, complexed with primer‐template DNA in the presence or absence of the incoming nucleoside triphosphate, the pre‐ and post‐translocated states, respectively. Comparison of these structures reveals a mechanism of translocation that appears to be facilitated by the coordinated movement of two conserved tyrosine residues into the insertion site. This differs from the mechanism employed by the A‐family polymerases, in which a conserved tyrosine moves into the templating and insertion sites during the translocation step. Polymerases from the two families also interact with downstream single‐stranded template DNA in very different ways.
Bibliography:istex:C9F69990D20DC7B316034FC350271F89AAFE05E9
ArticleID:EMBJ7601780
Supplementary MovieSupplementary Figure S1Supplementary Figure S2Supplementary Figure S3Supplementary DataSupplementary Data
ark:/67375/WNG-9X3J6B79-M
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
DE-AC02-98CH10886
BNL-80556-2008-JA
Doe - Office Of Science
Present address: Pfizer Inc., 700 Chesterfield Parkway West, Chesterfield, MO 63017, USA
ISSN:0261-4189
1460-2075
DOI:10.1038/sj.emboj.7601780